Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” third-quarter ...

Dr. Vipulroy Rathod, leading gastroenterologist in Mumbai, pioneers advanced minimally invasive endoscopy (EUS, ERCP) for ...

We at CUHKMC hope to be a business with conscience in terms of pricing, and so everyone can trust us,’ hospital CEO says.

Return on Equity (ROE): Merit Medical Systems's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 2.23%, the company showcases efficient ...

Discover Merit Medical Systems’ Q3 2025 earnings highlights—record margins, revenue growth, and strategic outlook under new CEO leadership.

Medical device company Merit Medical Systems (NASDAQ:MMSI) announced better-than-expected revenue in Q3 CY2025, with sales up ...

Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing ...

The new long-term results follow two-month data released at ASCO in June 2025 and are drawn from the largest prospective, randomized controlled study ever conducted among head and neck cancer ...

Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced 24-month efficacy findings from the non-randomized AVG cohort of the WAVE trial. Results of the ...

Q3 2025 Earnings Call Transcript October 30, 2025 Merit Medical Systems, Inc. beats earnings expectations. Reported EPS is $0 ...

Merit Medical Systems, Inc. MMSI reported third-quarter 2025 adjusted earnings per share (EPS) of 92 cents, up 6.9% from the ...

For decades, stroke patients with swallowing difficulties have routinely received crushed tablets to reduce the risk of ...